Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
PRPOthis companyPrecipio, Inc.	$19.32	-99.91×	2.53×	1.53×	23.6×	-1502.7%	44.5%	-5.0%	-1.5%	-2.5%	-6.6%	1.0%	0.25×	-1.63×	-16.47×	1.61×	0.0%	5	-2.69	1	C-
APUSApimeds Pharmaceuticals US, Inc	$2.69	-2.98×	0.12×	0×	-4.2×	-321.0%	0.0%	0.0%	0.0%	-3.9%	-7.4%	-50.3%	0.05×	-1.07×	-42.09×	1.31×	0.0%	1	-2.08	2	C+
INTSIntensity Therapeutics, Inc.	$2.93	-1.2×	1.17×	0×	-0.18×	143.3%	0.0%	0.0%	0.0%	-97.7%	-99.9%	-66.3%	0.01×	1.02×	0×	5.92×	0.0%	2	-10.06	3	B
MLSSMilestone Scientific Inc.	$0.31	-3.9×	7.97×	2.5×	-4.05×	-405.4%	70.5%	-63.5%	-63.8%	-203.4%	-148.6%	-13.1%	0.36×	0.02×	-222.53×	1.81×	0.0%	3	-19.32	1	C-
MODDModular Medical, Inc.	$1.57	-0.43×	0.93×	0×	-0.21×	36.8%	0.0%	0.0%	0.0%	-217.9%	-206.4%	-229.5%	0.03×	0.25×	0×	4.03×	0.0%	1	-14.77	3	B-
POCIPrecision Optics Corporation, Inc.	$5.03	-11.86×	2.14×	1.38×	-11.8×	-803.5%	17.2%	-11.1%	-11.5%	-17.8%	-14.4%	-4.5%	0.2×	1.81×	-23.69×	2.28×	0.0%	5	1.05	2	C
Peer median	—	-2.98×	1.17×	0×	-4.05×	-321.0%	0.0%	0.0%	0.0%	-97.7%	-99.9%	-50.3%	0.05×	0.25×	-23.69×	2.28×	0.0%	2	-10.06	2	—